Jan 21, 2026
On June 13, 2024, the Senate voted on the Right to IVF Act, which did not pass, falling short at 48-47. In a nutshell, the Senate decided not to advance the bill that would have established federal protections for in vitro fertilization (“IVF”). At Tate Healey Webster, we understand how critical this decision is for many aspiring parents relying on IVF.
The Right to IVF Act aimed to provide national access to individuals to receive IVF treatment and for doctors to provide said treatment. It also sought to make IVF treatment more affordable by mandating fertility treatment coverage through employer-sponsored insurance and certain public insurance plans, and it expanded U.S. military service and veterans’ healthcare coverage of fertility treatments.
The bill’s failure impacts accessibility and affordability of IVF treatments, leaving many families without the support they need. As advocates for family building, this outcome is deeply significant to our community.
Tate Healey Webster remains committed to supporting individuals and couples affected by this decision. We continue to advocate for legislative improvements and provide expert legal guidance to those navigating the complexities of fertility treatments.
Stay informed and engaged with legislative changes that affect family building. If you need guidance or support regarding IVF or other artificial reproductive technology law, our doors are always open.
This setback highlights the ongoing need for advocacy in reproductive rights and access to fertility treatments. Tate Healey Webster is here to help you face these challenges, ensuring your journey to parenthood is supported every step of the way.
Contact us at (800) 874-4916 for more information.
To read more about the Senate IVF Bill please visit:https://www.cnn.com/2024/06/13/politics/senate-ivf-bill-vote/index.html
